The purpose of this category of interview questions is to obtain factual information about the interviewee.
Answer:
a.
Debit Accounts Receivable $1,500
Credit Sales $1,500
b.
Debit Cash $1,500
Credit Accounts Receivable $1,500
Explanation:
On June 7, Pixer Co. sells $1500 of merchandise to Jasmine Co. on account.
Pixer's books records the sale by the entry:
Debit Accounts Receivable $1,500
Credit Sales $1,500
On June 21, Jasmine Co. pays for this merchandise. Pixer's books records the receipt of payment by the entry:
Debit Cash $1,500
Credit Accounts Receivable $1,500
Answer:
The Journal entry that Oriole Company will make to pay off the note and interest at maturity assuming that interest has been accrued to September 30 will be:
Dr Notes Payable 560,000
Dr Interest Payable 25,200
(560,000*6%*9/12)
Cr Cash 585,200
(560,000+25,200)
Explanation:
Based on the information given where Moss County Bank agrees to lend the Oriole Company $560000 on January 1 this means we have to Debit Note payable with 560,000 and since Oriole Company signs a $560000, 6%, 9-month this means we have to Debit Interest payable with 25,200 (560,000*6%*9/12) and Credit Cash with 585,200 (560,000+25,200).
Answer:
The net cash provided by investing activities on the statement of cash flows will be $106,000
Explanation:
Investing activities include all the cash transactions incurred for the fixed asset of the company.
The net cash provided by (used in) investing activities can be calculated as follows
Net cash provided by (used in) investing activities = Sale of long-term investment + Collection by McCorey of a loan made to another company
Where
Sale of long-term investment = $60,000 ( Cash inflow )
Collection by McCorey of a loan made to another company = $46,000 ( Cash Inflow )
Placing values in the fomrula
Net cash provided by investing activities = $60,000 + $46,000 = $106,000
Answer:
$800 million; more than a decade
Explanation:
If a pharmaceutical firm decides to develop a new drug. On average, it can cost $800 million and take more than a decade to discover a new drug, perform the necessary safety tests, and bring the drug to market.
